{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:22:47Z","timestamp":1790623367123,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["101020\/Z\/13\/Z"],"award-info":[{"award-number":["101020\/Z\/13\/Z"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["106917\/Z\/15\/Z"],"award-info":[{"award-number":["106917\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","bmn.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.pt.2020.04.003","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T12:39:15Z","timestamp":1588077555000},"page":"545-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target"],"prefix":"10.1016","volume":"36","author":[{"given":"Robert J.","family":"Ragotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew K.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9415-1357","authenticated-orcid":false,"given":"Simon J.","family":"Draper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2020.04.003_bb0005","series-title":"World Malaria Report 2019","author":"WHO","year":"2019"},{"key":"10.1016\/j.pt.2020.04.003_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000324","article-title":"Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies","volume":"7","author":"Griffin","year":"2010","journal-title":"PLoS Med."},{"key":"10.1016\/j.pt.2020.04.003_bb0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/192733a0","article-title":"Gamma-globulin and acquired immunity to human malaria","volume":"192","author":"Cohen","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.pt.2020.04.003_bb0020","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-year efficacy of RTS,S\/AS01 malaria vaccine among young African children","volume":"374","author":"Olotu","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2020.04.003_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-017-0923-4","article-title":"Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial","volume":"15","author":"Walk","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.pt.2020.04.003_bb0030","author":"Steinhardt","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2020.04.003_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000490","article-title":"Resurrection of the ancestral RH5 invasion ligand provides a molecular explanation for the origin of P. falciparum malaria in humans","volume":"17","author":"Galaway","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pt.2020.04.003_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria vaccines: recent advances and new horizons","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pt.2020.04.003_bb0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.chom.2014.11.017","article-title":"A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys","volume":"17","author":"Douglas","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pt.2020.04.003_bb0050","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ni.f.205","article-title":"Immunity to malaria: more questions than answers","volume":"9","author":"Langhorne","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.pt.2020.04.003_bb0055","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1008115","article-title":"A field trial to assess a blood-stage malaria vaccine","volume":"365","author":"Thera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2020.04.003_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3024.1987.tb00483.x","article-title":"Kinetic constraints on the development of a malaria vaccine","volume":"9","author":"Saul","year":"1987","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.pt.2020.04.003_bb0065","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1016\/j.vaccine.2015.09.094","article-title":"Progress with viral vectored malaria vaccines: A multi-stage approach involving 'unnatural immunity'","volume":"33","author":"Ewer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2020.04.003_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131456","article-title":"Analysis of a multi-component multi-stage malaria vaccine candidate \u2013 tackling the cocktail challenge","volume":"10","author":"Boes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2020.04.003_bb0075","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.vaccine.2014.03.020","article-title":"A multi-stage malaria vaccine candidate targeting both transmission and asexual parasite life-cycle stages","volume":"32","author":"Theisen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2020.04.003_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/dde6c172-c9c3-43bb-8fc3-db54613d4424","article-title":"PfRH5: a novel reticulocyte-binding family homolog of Plasmodium falciparum that binds to the erythrocyte, and an investigation of its receptor","volume":"3","author":"Rodriguez","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2020.04.003_bb0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.chom.2008.06.001","article-title":"Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion","volume":"4","author":"Hayton","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pt.2020.04.003_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002199","article-title":"An EGF-like protein forms a complex with PfRh5 and is required for invasion of human erythrocytes by Plasmodium falciparum","volume":"7","author":"Chen","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2020.04.003_bb0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ijpara.2008.10.006","article-title":"Reticulocyte-binding protein homologue 5 \u2013 an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum","volume":"39","author":"Baum","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2020.04.003_bb0100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature13715","article-title":"Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies","volume":"515","author":"Wright","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pt.2020.04.003_bb0105","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.04187","article-title":"Crystal structure of PfRh5, an essential P. falciparum ligand for invasion of human erythrocytes","volume":"3","author":"Chen","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.pt.2020.04.003_bb0110","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1073\/pnas.1516512113","article-title":"Structurally conserved erythrocyte-binding domain in Plasmodium provides a versatile scaffold for alternate receptor engagement","volume":"113","author":"Gruszczyk","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.04.003_bb0115","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1073\/pnas.1415466112","article-title":"Multiprotein complex between the GPI-anchored CyRPA with PfRH5 and PfRipr is crucial for Plasmodium falciparum erythrocyte invasion","volume":"112","author":"Reddy","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.04.003_bb0120","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chom.2016.06.004","article-title":"Essential role of the PfRh5\/PfRipr\/CyRPA complex during Plasmodium falciparum invasion of erythrocytes","volume":"20","author":"Volz","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pt.2020.04.003_bb0125","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1038\/ncomms14333","article-title":"P113 is a merozoite surface protein that binds the N terminus of Plasmodium falciparum RH5","volume":"8","author":"Galaway","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2020.04.003_bb0130","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/cmi.12596","article-title":"Proteomic analysis reveals novel proteins associated with the Plasmodium protein exporter PTEX and a loss of complex stability upon truncation of the core PTEX component, PTEX150","volume":"18","author":"Elsworth","year":"2016","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.pt.2020.04.003_bb0135","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature10606","article-title":"Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum","volume":"480","author":"Crosnier","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pt.2020.04.003_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007809","article-title":"Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites","volume":"15","author":"Knuepfer","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2020.04.003_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11078","article-title":"Genomes of cryptic chimpanzee Plasmodium species reveal key evolutionary events leading to human malaria","volume":"7","author":"Sundararaman","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2020.04.003_bb0150","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41564-018-0162-2","article-title":"Genomes of all known members of a Plasmodium subgenus reveal paths to virulent human malaria","volume":"3","author":"Otto","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.pt.2020.04.003_bb0155","doi-asserted-by":"crossref","first-page":"20735","DOI":"10.1073\/pnas.1320771110","article-title":"RH5-Basigin interaction plays a major role in the host tropism of Plasmodium falciparum","volume":"110","author":"Wanaguru","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.04.003_bb0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.molbiopara.2012.12.005","article-title":"Various PfRH5 polymorphisms can support Plasmodium falciparum invasion into the erythrocytes of owl monkeys and rats","volume":"187","author":"Hayton","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2020.04.003_bb0165","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.vaccine.2011.11.012","article-title":"A single amino acid change in the Plasmodium falciparum RH5 (PfRH5) human RBC binding sequence modifies its structure and determines species-specific binding activity","volume":"30","author":"Arevalo-Pinzon","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2020.04.003_bb0170","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02237-17","article-title":"Adaptive evolution of RH5 in ape Plasmodium species of the Laverania subgenus","volume":"9","author":"Plenderleith","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.pt.2020.04.003_bb0175","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.chom.2017.07.003","article-title":"The molecular basis of erythrocyte invasion by malaria parasites","volume":"22","author":"Cowman","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pt.2020.04.003_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12747","article-title":"P. falciparum RH5-Basigin interaction induces changes in the cytoskeleton of the host RBC","volume":"19","author":"Aniweh","year":"2017","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.pt.2020.04.003_bb0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41586-018-0779-6","article-title":"Structure of Plasmodium falciparum Rh5\u2013CyRPA\u2013Ripr invasion complex","volume":"565","author":"Wong","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.pt.2020.04.003_bb0190","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2019.05.025","article-title":"Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies","volume":"178","author":"Alanine","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.pt.2020.04.003_bb0195","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/ncomms1615","article-title":"The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody","volume":"2","author":"Douglas","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2020.04.003_bb0200","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.vaccine.2012.10.106","article-title":"A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants","volume":"31","author":"Bustamante","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2020.04.003_bb0205","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/IAI.00970-13","article-title":"Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies","volume":"82","author":"Reddy","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2020.04.003_bb0210","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96381","article-title":"Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions","volume":"2","author":"Payne","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.pt.2020.04.003_bb0215","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/infdis\/jit553","article-title":"Naturally acquired antibodies specific for Plasmodium falciparum reticulocyte-binding protein homologue 5 inhibit parasite growth and predict protection from malaria","volume":"209","author":"Tran","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2020.04.003_bb0220","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fmicb.2014.00314","article-title":"Association of antibodies to Plasmodium falciparum reticulocyte binding protein homolog 5 with protection from clinical malaria","volume":"5","author":"Chiu","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.pt.2020.04.003_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13030","article-title":"Neutralizing antibodies block the function of Rh5\/Ripr\/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes","volume":"21","author":"Healer","year":"2019","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.pt.2020.04.003_bb0230","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4049\/jimmunol.1300778","article-title":"Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development","volume":"191","author":"Richards","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.pt.2020.04.003_bb0235","article-title":"Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria","volume":"13","author":"Partey","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2020.04.003_bb0240","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008705","article-title":"New antigens for a multicomponent blood-stage malaria vaccine","volume":"6","author":"Osier","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2020.04.003_bb0245","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/s41467-019-09894-4","article-title":"A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates","volume":"10","author":"Douglas","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pt.2020.04.003_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00524","article-title":"Plasmodium falciparum liver stage infection and transition to stable blood stage infection in liver-humanized and blood-humanized FRGN KO mice enables testing of blood stage inhibitory antibodies (reticulocyte-binding protein homolog 5) in vivo","volume":"9","author":"Foquet","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2020.04.003_bb0255","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.1302045","article-title":"Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5","volume":"192","author":"Douglas","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.pt.2020.04.003_bb0260","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/infdis\/jit385","article-title":"Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans","volume":"208","author":"Patel","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2020.04.003_bb0265","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41577-019-0209-5","article-title":"Antibodies against Plasmodium falciparum malaria at the molecular level","volume":"19","author":"Julien","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.pt.2020.04.003_bb0270","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1016\/j.vaccine.2015.09.093","article-title":"Recent advances in recombinant protein-based malaria vaccines","volume":"33","author":"Draper","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2020.04.003_bb0275","doi-asserted-by":"crossref","first-page":"30357","DOI":"10.1038\/srep30357","article-title":"Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system","volume":"6","author":"Hjerrild","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2020.04.003_bb0280","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijpara.2016.12.001","article-title":"Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag'","volume":"47","author":"Jin","year":"2017","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2020.04.003_bb0285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41541-018-0071-7","article-title":"Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells","volume":"3","author":"Jin","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.pt.2020.04.003_bb0290","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/infdis\/jiw039","article-title":"Demonstration of the blood-stage Plasmodium falciparum controlled human malaria infection model to assess efficacy of the P. falciparum apical membrane antigen 1 vaccine, FMP2.1\/AS01","volume":"213","author":"Payne","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2020.04.003_bb0295","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1073\/pnas.1616903114","article-title":"One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen","volume":"114","author":"Campeotto","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.04.003_bb0300","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nbt.1597","article-title":"Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum","volume":"28","author":"Hu","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pt.2020.04.003_bb0305","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1016\/j.vaccine.2016.09.028","article-title":"Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate","volume":"34","author":"Ntege","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2020.04.003_bb0310","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.4049\/jimmunol.1103177","article-title":"Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen","volume":"188","author":"Dreyer","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.pt.2020.04.003_bb0315","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.21347","article-title":"Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPA","volume":"6","author":"Chen","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.pt.2020.04.003_bb0320","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.20383","article-title":"Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody","volume":"6","author":"Favuzza","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.pt.2020.04.003_bb0325","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12936-016-1213-x","article-title":"Generation of Plasmodium falciparum parasite-inhibitory antibodies by immunization with recombinantly-expressed CyRPA","volume":"15","author":"Favuzza","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.pt.2020.04.003_bb0330","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-0158-9","article-title":"Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models","volume":"5","author":"Tamborrini","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.pt.2020.04.003_bb0335","doi-asserted-by":"crossref","first-page":"12045","DOI":"10.1073\/pnas.1702944114","article-title":"Synergistic malaria vaccine combinations identified by systematic antigen screening","volume":"114","author":"Bustamante","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.04.003_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01254","article-title":"Functional comparison of blood-stage Plasmodium falciparum malaria vaccine candidate antigens","volume":"10","author":"Illingworth","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2020.04.003_bb0345","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1073\/pnas.1409928111","article-title":"Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria","volume":"111","author":"Srinivasan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.04.003_bb0350","doi-asserted-by":"crossref","first-page":"407","DOI":"10.15252\/emmm.201505986","article-title":"Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis","volume":"8","author":"De Benedictis","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.pt.2020.04.003_bb0355","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/IAI.00815-08","article-title":"An engineered human antibody fab fragment specific for Pseudomonas aeruginosa PcrV antigen has potent antibacterial activity","volume":"77","author":"Baer","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2020.04.003_bb0360","doi-asserted-by":"crossref","first-page":"C15","DOI":"10.1016\/j.vaccine.2009.06.008","article-title":"Essential criteria for evaluation of pneumococcal conjugate vaccine candidates","volume":"27","author":"Paradiso","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2020.04.003_bb0365","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.aav9033","article-title":"A proof of concept for structure-based vaccine design targeting RSV in humans","volume":"365","author":"Crank","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.pt.2020.04.003_bb0370","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1073\/pnas.1110303108","article-title":"Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion","volume":"108","author":"Srinivasan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2020.04.003_bb0375","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1128\/IAI.70.10.5751-5758.2002","article-title":"Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites","volume":"70","author":"Healer","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2020.04.003_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0010017","article-title":"Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles","volume":"1","author":"Alexander","year":"2005","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.pt.2020.04.003_bb0385","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tcb.2004.08.002","article-title":"The glideosome: a molecular machine powering motility and host-cell invasion by Apicomplexa","volume":"14","author":"Keeley","year":"2004","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.pt.2020.04.003_bb0390","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijpara.2008.09.007","article-title":"Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites","volume":"39","author":"Gilson","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2020.04.003_bb0395","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cell.2006.02.006","article-title":"Invasion of red blood cells by malaria parasites","volume":"124","author":"Cowman","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.pt.2020.04.003_bb0400","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/IAI.73.6.3677-3685.2005","article-title":"Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria","volume":"73","author":"Malkin","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2020.04.003_bb0405","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1182\/blood-2004-10-4047","article-title":"Malaria-specific transgenic CD4+ T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance","volume":"106","author":"Stephens","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pt.2020.04.003_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020547","article-title":"Vaccination with Plasmodium knowlesi AMA1 formulated in the novel adjuvant co-vaccine HT\u2122 protects against blood-stage challenge in rhesus macaques","volume":"6","author":"Mahdi Abdel Hamid","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2020.04.003_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003571","article-title":"Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum","volume":"3","author":"McCallum","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2020.04.003_bb0420","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.pt.2008.08.008","article-title":"Recent insights into humoral and cellular immune responses against malaria","volume":"24","author":"Beeson","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2020.04.003_bb0425","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1128\/IAI.00960-09","article-title":"In vitro growth-inhibitory activity and malaria risk in a cohort study in Mali","volume":"78","author":"Crompton","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2020.04.003_bb0430","article-title":"An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples","author":"Pearson","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.pt.2020.04.003_bb0435","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera \u2013 a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492220300994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492220300994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T01:18:14Z","timestamp":1739323094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492220300994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1471492220300994"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2020.04.003","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2020.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}